Zinc Deficiency and Intestinal Permeability in the Context of Rational Diagnostic and Drug Development for Diarrhea-Predominant Irritable Bowel Syndrome

被引：0
|
作者：
Eric D. Shah
机构：
[1] Dartmouth-Hitchcock Medical Center,Division of Gastroenterology and Hepatology, Center for Gastrointestinal Motility, Esophageal, and Swallowing Disorders
来源：
Digestive Diseases and Sciences | 2022年 / 67卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3477 / 3478
页数：1
相关论文
共 50 条
  • [21] Alosetron: an effective treatment for diarrhea-predominant irritable bowel syndrome
    Harris, Lucinda A.
    Chang, Lin
    WOMENS HEALTH, 2007, 3 (01) : 15 - 27
  • [22] Increased intestinal mucosal leptin levels in patients with diarrhea-predominant irritable bowel syndrome
    Liu, De-Rong
    Xu, Xiao-Juan
    Yao, Shu-Kun
    WORLD JOURNAL OF GASTROENTEROLOGY, 2018, 24 (01) : 46 - 57
  • [23] Increased intestinal mucosal leptin levels in patients with diarrhea-predominant irritable bowel syndrome
    De-Rong Liu
    Xiao-Juan Xu
    Shu-Kun Yao
    World Journal of Gastroenterology, 2018, (01) : 46 - 57
  • [24] Development and Validation of a Biomarker for Diarrhea-Predominant Irritable Bowel Syndrome in Human Subjects
    Pimentel, Mark
    Morales, Walter
    Rezaie, Ali
    Marsh, Emily
    Lembo, Anthony
    Mirocha, James
    Leffler, Daniel A.
    Marsh, Zachary
    Weitsman, Stacy
    Chua, Kathleen S.
    Barlow, Gillian M.
    Bortey, Enoch
    Forbes, William
    Yu, Allen
    Chang, Christopher
    PLOS ONE, 2015, 10 (05):
  • [25] Mesalamine Improve Symptoms of Diarrhea-Predominant Irritable Bowel Syndrome
    Bafutto, Mauro
    Bafutto, Alexandre A.
    Oliveira, Enio C.
    Rezende Filho, Joffre
    GASTROENTEROLOGY, 2013, 144 (05) : S540 - S540
  • [26] The Fecal Microbiome in Children With Diarrhea-Predominant Irritable Bowel Syndrome
    Michail, Sonia
    Kenche, Harshavadran
    GASTROENTEROLOGY, 2010, 138 (05) : S14 - S14
  • [27] Rifaximin in the Treatment of Patients With Diarrhea-Predominant Irritable Bowel Syndrome
    Dai, Cong
    Jiang, Min
    Sun, Ming-Jun
    GASTROENTEROLOGY, 2017, 152 (06) : 1629 - +
  • [28] Targeting diarrhea-predominant irritable bowel syndrome: hopes or hypes?
    Bassotti, Gabrio
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2024,
  • [29] Decreased mucosal cytokines in diarrhea-predominant irritable bowel syndrome
    Chang, L
    Anton, P
    Elliott, J
    Reinholdt, J
    Taing, P
    Mayer, E
    GASTROENTEROLOGY, 2002, 122 (04) : A552 - A552
  • [30] RIFAXIMIN IS A SAFE THERAPY FOR DIARRHEA-PREDOMINANT IRRITABLE BOWEL SYNDROME
    Weinstock, Leonard B.
    Pimentel, Mark
    Heimanson, Zeev
    Lembo, Anthony
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2018, 33 : S331 - S332
12345